Does your daily checklist look like this? It might be Sjögren's disease. | Johns Hopkins Medicine

A first-of-its-kind therapy based on research at Johns Hopkins Medicine was approved by FDA for Barth syndrome, a rare disease that causes muscle and heart weakness and shortened lifespans. This approval could lead to development of similar therapies for mitochondrial disorders, which affect 1 in 5,000 people worldwide. | Johns Hopkins Medicine

Every life-saving discovery starts with an idea—a tiny seed of innovation. Johns Hopkins University provides the foundation for groundbreaking research, while federal funds from institutions like the NIH help these ideas grow into real-world solutions. Because our research doesn’t just inform—it saves lives. https://hub.jhu.edu/2025/03/04/sarah-szanton-nih-grants-aging/ #ResearchSavesLives | Johns Hopkins University

Nearly one year ago, the Key Bridge collapse changed lives in Baltimore. Today, Johns Hopkins researchers are working to prevent the next tragedy—using data to spot the country’s most vulnerable bridges. This is how research can help protect families, communities, and futures. https://hub.jhu.edu/2025/03/24/major-bridges-high-risk-ship-collisions/ #ResearchSavesLives | Johns Hopkins University